![Rainer Fischer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rainer Fischer
Director/Miembro de la Junta en Indiana Biosciences Research Institute .
Cargos activos de Rainer Fischer
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Director/Miembro de la Junta | - | - |
Corporate Officer/Principal | 19/04/2019 | - | |
Director Ejecutivo | 01/10/2017 | 19/04/2019 | |
Director Técnico/Científico/I+D | 01/10/2016 | 19/04/2019 |
Historial de carrera de Rainer Fischer
Estadísticas
Internacional
Estados Unidos | 2 |
Operativa
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Indiana Biosciences Research Institute
![]() Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services The Indiana Biosciences Research Institute is a biomedical research organization that aims to solve challenging health problems and improve patient outcomes. The Eli Lilly and Company Diabetes Center of Excellence, located at the institute, is dedicated to studying the molecular basis of diabetes and its complications. The non-profit company is based in Indianapolis, IN. The company's research focuses on translating disease hypotheses into potential therapies. Alan Palkowitz has been the CEO of the company since 2020. | Commercial Services |
- Bolsa de valores
- Insiders
- Rainer Fischer
- Experiencia